Javier Fernández-Ruiz obtained a PhD in Biochemistry in 1986 from the Complutense University, Madrid, Spain. He is currently full professor of biochemistry and molecular biology in the Faculty of Medicine there. Over the past 40 years, he has worked on different CNS diseases and has authored 253 research articles, 45 review articles, 42 book chapters and 8 international patents. He has supervised 24 doctoral students and given numerous lectures at different national and international universities and research centers, as well as numerous presentations at national and international congresses. He is currently the PI of the “Cannabinoids and Neurological Disorders” research group at the Complutense University and at two cooperative networks of excellence research in Spain: CIBERNED and IRYCIS. He has participated in numerous research projects, including 8 research contracts with pharma companies, and he is currently a member of the editorial board for the British Journal of Pharmacology.
Associated Grants
-
Investigating GPR55 as a Novel Neuroprotective Target in Preclinical Models of Parkinson’s Disease
2022
-
Cannabinoid CB2 Receptors as a New Target for the Treatment of Disease Progression in Parkinson's Disease: Studies in LRRK2-Transgenic Pre-clinical Models
2012